Oyster Point Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 359,372 | 1.32% |
General Public | 2,643,570 | 9.74% |
Institutions | 6,289,559 | 23.2% |
Hedge Funds | 8,269,362 | 30.5% |
VC/PE Firms | 9,582,905 | 35.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,925,287 | US$66.2m | 0% | 3.01% | |||
3,657,618 | US$40.9m | 0% | 8.5% | |||
2,768,586 | US$30.9m | 0% | 16.19% | |||
2,044,312 | US$22.8m | -0.69% | 0.46% | |||
1,808,148 | US$20.2m | -4.42% | 0.05% | |||
1,648,316 | US$18.4m | 23.6% | 2.46% | |||
1,039,622 | US$11.6m | 0% | 0.11% | |||
777,026 | US$8.7m | 0% | 1.29% | |||
564,856 | US$6.3m | 21.6% | 0.06% | |||
509,794 | US$5.7m | 0% | 0.46% | |||
504,373 | US$5.6m | -5.42% | no data | |||
427,095 | US$4.8m | -35.9% | no data | |||
367,987 | US$4.1m | 0% | 0.67% | |||
296,058 | US$3.3m | 32.5% | no data | |||
210,200 | US$2.3m | 0% | 0.06% | |||
205,238 | US$2.3m | -3.23% | no data | |||
203,167 | US$2.3m | 101% | no data | |||
155,171 | US$1.7m | 27.3% | no data | |||
140,893 | US$1.6m | 1.28% | no data | |||
118,513 | US$1.3m | 0% | no data | |||
106,662 | US$1.2m | 0% | no data | |||
106,551 | US$1.2m | -20.9% | no data | |||
95,686 | US$1.1m | -0.16% | no data | |||
83,537 | US$933.1k | -10.3% | no data | |||
77,427 | US$864.9k | -24.8% | no data |